$HURA

$2.22▲ +1.8% YTD

6 SEC 13D/G filings tracked · Last updated Oct 26, 2026

Filing History

CP $2.22▲ +1.8%Oct 26, 2026 · ThinkSabio Blog

$HURA HURA - TuHURA Biosciences Provides First Look at Data from its Open-Label Study of IFx-2.0 as an Adjunctive Therapy to Keytruda® in First Line T…

News

HURA ▲ +2.6% - TuHURA Biosciences, Inc.

CP $1.95▲ +2.6%Oct 13, 2026 · ThinkSabio Blog

$HURA HURA - TuHURA Biosciences Receives New U.S. Patent Broadening Coverage for its VISTA Inhibitor, TBS-2025…

News

HURA ▲ +4.2% - TuHURA Biosciences, Inc.

CP $2.00▲ +4.2%Oct 5, 2026 · ThinkSabio Blog

$HURA HURA - TuHURA Biosciences Receives Key U.S. Patent for its Groundbreaking Delta Opioid Receptor (DOR) Antibody Drug Conjugate (ADC) Technology…

News

HURA ▲ +4.9% - TuHURA Biosciences, Inc.

CP $2.15▲ +4.9%Sep 14, 2026 · ThinkSabio Blog

$HURA HURA - TuHURA Biosciences Receives FDA "Study May Proceed" Notice and IND Clearance for the Evaluation of its TBS-2025 VISTA-Inhibiting Antibody…

News

HURA ▼ -2.3% - TuHURA Biosciences, Inc.

CP $2.09▲ -2.3%Sep 8, 2026 · ThinkSabio Blog

$HURA HURA - TuHURA Biosciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference…

SEC 13D/G

HURA - TuHURA Biosciences, Inc. - SEC Filing Update (28-AUG-2026) | ThinkSabio - Stocks Simplified

$2.11▲ 181.33%Aug 28, 2026 · ThinkSabio Blog

$HURA SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #HURA TuHURA Biosciences, Inc. : $2.11 Sector: Healthcare | YTD:…